
Imunon Investor Relations Material
Latest events

Q2 2025
Imunon
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Imunon Inc
Access all reports
Imunon Inc. is a clinical-stage biotechnology company focused on the development of innovative therapies for oncology and infectious diseases. The company utilizes its proprietary ThermoDox platform, which combines heat-activated liposomal drug delivery with targeted chemotherapy to enhance treatment effectiveness. Imunon also engages in the development of DNA-based vaccines and immunotherapies aimed at improving patient outcomes. The company is headquartered in Lawrenceville, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
IMNN
Country
🇺🇸 United States